Jo Vandervoort - Concepedia

Author

Jo Vandervoort

Also Known As

J Vandervoort, J. Vandervoort, Jo G. Vandervoort, Jo G.P. Vandervoort, Jo Gp Vandervoort, Jo Vandervoort, Jo. Vandervoort, Johan Vandervoort, VANDERVOORT J

108

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

University of Antwerp Brigham and Women's Hospital Onze Lieve Vrouwziekenhuis Hospital Harvard University Bispebjerg Hospital

About

Jo Vandervoort is an author at University of Antwerp specializing in medicine, surgery, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	2.2K
2	Engineering	9	9	746
3	Biomedical Engineering	4	4	562
4	Biomolecular Engineering	3	3	184
5	Public Health	1	1	152

Jo Vandervoort

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Risk factors for complications after performance of ERCP Jo Vandervoort, Roy Soetikno, Tony Tham, Gastrointestinal Endoscopy Adverse EventPatient SafetyMedical Error PreventionRiskOutcomes Research	2002	586
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline Jeanin E. van Hooft, Emo E. van Halsema, Geoffroy Vanbiervliet, Gastrointestinal Endoscopy Self-expandable Metal StentsMedicineGastroenterologyLumen-apposing Metal StentSurgery	2014	344
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline Jeanin E. van Hooft, Emo van Halsema, Geoffroy Vanbiervliet, Endoscopy	2014	330
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2020 Jeanin E. van Hooft, Joyce Veld, Dirk Arnold, Endoscopy	2020	330
Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use Jo Vandervoort, A. Ludwig European Journal of Pharmaceutics and Biopharmaceutics Tissue EngineeringNanomedicineDrug-loaded Gelatin NanoparticlesEngineeringOphthalmology	2003	245
Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study Jo Vandervoort, A. Ludwig International Journal of Pharmaceutics NanoparticlesNanomedicineBiocompatible StabilizersEngineeringGreen Synthesis	2002	234
Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy Martine De Vos, Édouard Louis, Jørgen Jahnsen, Inflammatory Bowel Diseases	2013	202
Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies Pelin Aksungur, Murat Demirbilek, Emir Baki Denkbaş, Journal of Controlled Release NanomedicineOphthalmologyMedicineCellular ToxicityPharmaceutical Nanotechnology	2011	175
Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles Kathleen Dillen, Jo Vandervoort, Guy Van den Mooter, International Journal of Pharmaceutics Green SynthesisCiprofloxacin-plga Nanoparticles	2004	173
Safety of ERCP during pregnancy Tony Tham, Jo Vandervoort, Richard C.K. Wong, The American Journal of Gastroenterology Biliary TractMaternal Cardiovascular OutcomeInterventional Endoscopic UltrasoundPatient SafetyGastroenterology	2003	152

Page 1